Sales rise 25.76% to Rs 916.91 crore
Net loss of Jubilant Life Sciences reported to Rs 78.58 crore in the quarter ended September 2013 as against net profit of Rs 83.60 crore during the previous quarter ended September 2012. Sales rose 25.76% to Rs 916.91 crore in the quarter ended September 2013 as against Rs 729.12 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales916.91729.12 26 OPM %19.0216.86 -PBDT111.3669.93 59 PBT67.4533.07 104 NP-78.5883.60 PLPowered by Capital Market - Live News